中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

肝硬化食管胃底静脉曲张的内镜诊断治疗——从指南到临床实践

丁惠国 张世斌 李磊 李鹏 张月宁 王贞彪

引用本文:
Citation:

肝硬化食管胃底静脉曲张的内镜诊断治疗——从指南到临床实践

DOI: 10.3969/j.issn.1001-5256.2017.03.011
基金项目: 

北京市医院管理局感染消化内科重点专业(ZYLX201610); 登峰人才团队培养计划(DFL20151602); 

详细信息
  • 中图分类号: R575.2

Endoscopic diagnosis and treatment of esophageal and gastric varices in patients with liver cirrhosis:from guidelines to clinical practice

Research funding: 

 

  • 摘要: 肝硬化食管胃底静脉曲张出血是临床常见、病死率高的消化系统急重症,内镜是诊治的主要手段。选择适宜的内镜技术及时诊断和有效治疗是降低其病死率的关键。根据国内肝硬化门静脉高压症临床诊治相关指南及最新临床证据,简述了内镜在肝硬化食管胃底静脉曲张及其出血的诊断和治疗中的作用,包括内镜筛查与治疗时机、内镜硬化剂与套扎治疗方法的选择、内镜治疗失败的挽救措施、内镜治疗并发症及其处理。肝静脉压力梯度指导下,可提高个体化的内镜和(或)药物防治肝硬化食管胃底静脉曲张出血的效果。总之,内镜是肝硬化食管胃底静脉曲张出血诊治的主要手段,研究早期预测内镜治疗效果的因素,规范内镜诊治技术,对提高内镜治疗的效果及安全性具有重要意义。

     

  • [1]TSOCHATZIS EA, BOSCH J, BURROUGHS AK.Liver cirrhosis[J].Lancet, 2014, 383 (9930) :1749-1761.
    [2]de FRANCHIS R, BAVENO VI FACULTY.Expanding consensus in portal hypertension:report of the Baveno VI Consensus Workshop:stratifying risk and individualizing care for portal hypertension[J].J Hepatol, 2015, 63 (3) :745-752.
    [3]Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association;Chinese Society of Endoscopy, Chinese Medical Association.Guidelines for the diagnosis and treatment of esophageal and gastric variceal bleeding in cirrhotic portal hypertension[J].J Clin Hepatol, 2016, 32 (2) :203-219. (inC hinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会内镜学分会.肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J].临床肝胆病杂志, 2016, 32 (2) :203-219.
    [4]HWANG JH, SHERGILL AK, ACOSTA RD, et al.The role of endoscopy in the management of variceal hemorrhage[J].Gastrointest Endosc, 2014, 80 (2) :221-227.
    [5]COLLI A, GANA JC, TURNER D, et al.Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis[J].Cochrane Database Syst Rev, 2014, 10:CD008760.
    [6]DAI C, LIU WX, JIANG M, et al.Endoscopic variceal ligation compared with endoscopic injection sclerotherapy for treatment of esophageal variceal hemorrhage:a meta-analysis[J].World J Gastroenterol, 2015, 21 (8) :2534-2541.
    [7]TRIPATHI D, STANLEY AJ, HAYES PCN, et al.UK guidelines on the management of variceal haemorrhage in cirrhotic patients[J].Gut, 2015, 64 (11) :1680-1704.
    [8]KONDO T, MARUYAMA H, KIYONO S, et al.Eradication of esophageal varices by sclerotherapy combined with argon plasma coagulation:effect of portal hemodynamics and longitudinal clinical course[J].Dig Endosc, 2016, 28 (2) :152-161.
    [9]AGUILAR-OLIVOS N, MOTOLA-KUBA M, CANDIA R, et al.Hemodynamic effect of carvedilol vs.propranolol in cirrhotic patients:systematic review and meta-analysis[J].Ann Hepatol, 2014, 13 (4) :420-428.
    [10]CHEN J, ZENG XQ, MA LL, et al.Randomized controlled trial comparing endoscopic ligation with or without sclerotherapy for secondary prophylaxis of variceal bleeding[J].Eur J Gastroenterol Hepatol, 2016, 28 (1) :95-100.
    [11]BHARDWAJ A, KEDARISETTY CK, VASHISHTHA C, et al.Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis:a randomised placebo-controlled trial[J].Gut, 2016.[Epub ahead of print]
    [12]ZHANG SB, SONG YM, FENG L, et al.Efficacy and safety of endoscopic embolization with Glubran-2 glue for gastric varices in liver cirrhosis[J].ADRJ, 2014, 16 (3) :139-142. (in Chinese) 张世斌, 宋燕明, 封丽, 等.Glubran-2胶栓塞术治疗肝硬化胃静脉曲张的疗效和安全性观察[J].药物不良反应杂志, 2014, 16 (3) :139-142.
    [13]ZENG XQ, MA LL, TZENG YJ, et al.Endoscopic cyanoacrylate injection with or without lauromacrogol for gastric varices:a randomized pilot study[J].J Gastroenterol Hepatol, 2016.[Epub ahead of print]
    [14]QIAO WG, REN YT, BAI Y, et al.Cyanoacrylate injection versus band ligation in the endoscopic management of acute gastric variceal bleeding[J].Medicine (Baltimore) , 2015, 94 (41) :e1725.
    [15]KOCHHAR GS, NAVANEETHAN U, HARTMAN J, et al.Comparative study of endoscopy vs.transjugular intrahepatic portosystemic shunt in the management of gastric variceal bleeding[J].Gastroenterol Rep (Oxf) , 2015, 3 (1) :75-82.
    [16]HOLSTER IL, TJWA ET, MOELKER A, et al.Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy+β-blocker for prevention of variceal rebleeding[J].Hepatology, 2016, 63 (2) :581-589.
    [17]MISHRA SR, CHANDER SHARMA B, KUMAR A, et al.Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed:a randomised controlled trial[J].Gut, 2010, 59 (6) :729-35.
    [18]SAUERBRUCH T, MENGEL M, DOLLINGER M, et al.Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents versus hemodynamically controlled medical therapy[J].Gastroenterology, 2015, 149 (3) :660-668.
    [19]KANG SH, YIM HJ, KIM SY, et al.Proton pump inhibitor therapy is associated with reduction of early bleeding risk after rrophylactic endoscopic variceal band ligation[J].Medicine (Baltimore) , 2016, 95 (8) :e2903.
    [20]IBRAHIM M, MIKKAWY A-EI, ABDALLA H, et al.Management of acute variceal bleeding using hemostatic powder[J].United European Gastroenterol J, 2015, 3 (3) :277-283.
    [21]MAROT A, TREPO E, DOERIG C, et al.Liver stiffness and platelet count for identifying patients with compensated liver disease at low risk of variceal bleeding[J].Liver Int, 2016.[Epub ahead of print]
  • 加载中
计量
  • 文章访问数:  2599
  • HTML全文浏览量:  34
  • PDF下载量:  613
  • 被引次数: 0
出版历程
  • 出版日期:  2017-03-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回